Biostage posts webinar video; interim CEO outlines plans for clinical trial, capital raise, NASDAQ uplisting

Harvard Apparatus Regenerative Technology, Inc.

Biostage posted video of January 27 webinars with founder/interim CEO David Green.
Webinar covered plans for approved clinical trial, raising capital, and uplisting to NASDAQ.
Video includes Q&A sessions from both webinars.

item 8.01

Harvard Apparatus Regenerative Technology, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-011367

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.